Sunitinib objective response (OR) in metastatic renal cell carcinoma (mRCC): Analysis of 1,059 patients treated on clinical trials Meeting Abstract


Authors: Molina, A. M.; Zhang, J.; Lin, X.; Niculescu, L.; Korytowsky, B.; Matczak, E.; Wiltshire, R.; Motzer, R. J.
Abstract Title: Sunitinib objective response (OR) in metastatic renal cell carcinoma (mRCC): Analysis of 1,059 patients treated on clinical trials
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009802771
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.4542
Notes: Meeting Abstract: 4542 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer
  2. Jingbo Zhang
    37 Zhang
  3. Ana Maria Luisa Molina
    50 Molina